Evidence map›Paper›PMID 35822788›Full record

ArticleBiotech (Basel (Switzerland))2022

Xylanase Production by

Giórgia S Barbieri, Heitor B S Bento, Fernanda de Oliveira, Flávio P Picheli, Lídia M Dias, Fernando Masarin, Valéria C Santos-Ebinuma

Open access · goldAbstract read
In one paragraph

Article in Biotech (Basel (Switzerland)), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.0field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Giórgia S BarbieriDepartment of Engineering Bioprocess and Biotechnology, School of Pharmaceutical Sciences, São Paulo State University (UNESP), Rodovia Araraquara-Jau km. 01, Araraquara 14800-903, SP, Brazil.
Heitor B S BentoDepartment of Engineering Bioprocess and Biotechnology, School of Pharmaceutical Sciences, São Paulo State University (UNESP), Rodovia Araraquara-Jau km. 01, Araraquara 14800-903, SP, Brazil.ORCID 0000-0002-0629-3196
Fernanda de OliveiraDepartment of Engineering Bioprocess and Biotechnology, School of Pharmaceutical Sciences, São Paulo State University (UNESP), Rodovia Araraquara-Jau km. 01, Araraquara 14800-903, SP, Brazil.ORCID 0000-0001-9441-4113
Flávio P PicheliDepartment of Engineering Bioprocess and Biotechnology, School of Pharmaceutical Sciences, São Paulo State University (UNESP), Rodovia Araraquara-Jau km. 01, Araraquara 14800-903, SP, Brazil.
Lídia M DiasDepartment of Engineering Bioprocess and Biotechnology, School of Pharmaceutical Sciences, São Paulo State University (UNESP), Rodovia Araraquara-Jau km. 01, Araraquara 14800-903, SP, Brazil.
Fernando MasarinDepartment of Engineering Bioprocess and Biotechnology, School of Pharmaceutical Sciences, São Paulo State University (UNESP), Rodovia Araraquara-Jau km. 01, Araraquara 14800-903, SP, Brazil.ORCID 0000-0001-9948-3273
Valéria C Santos-EbinumaDepartment of Engineering Bioprocess and Biotechnology, School of Pharmaceutical Sciences, São Paulo State University (UNESP), Rodovia Araraquara-Jau km. 01, Araraquara 14800-903, SP, Brazil.ORCID 0000-0002-6666-6695
Universidade Estadual Paulista (Unesp) · BR

Funding

National Council for Scientific and Technological Development 312463/2021-9São Paulo Research Foundation 2014/01580-3, 2019/15493-9,2020/
6 · The paper itself

Abstract

In general, agroindustrial byproducts can be easily assimilated by several microorganisms due to their composition, which is rich in carbohydrates. Therefore, they could be appropriate for use as raw materials in a sustainable refinery concept, including the production of hydrolytic enzymes with industrial applicability. In this work, xylanase production by the filamentous fungi

Indexed as

agroindustrial byproductsenzymatic hydrolysissubmerged cultivationTalaromyces amestolkiaexylanase

Identifiers

PMID35822788
PMCPMC9264394
OpenAlexW4280626257

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.